Krishna V Komanduri

Professor

  • 4526 Citations
1992 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Krishna V Komanduri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    Angiosarcoma patients treated with immune checkpoint inhibitors: A case series of seven patients from a single institution

    Florou, V., Rosenberg, A. E., Wieder, E., Komanduri, K. V., Kolonias, D., Uduman, M., Castle, J. C., Buell, J. S., Trent, J. C. & Wilky, B. A., Aug 8 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 213.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    ASBMT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

    Lee, D. W., Santomasso, B. D., Locke, F. L., Ghobadi, A., Turtle, C. J., Brudno, J. N., Maus, M. V., Park, J. H., Mead, E., Pavletic, S., Go, W. Y., Eldjerou, L., Gardner, R. A., Frey, N., Curran, K. J., Peggs, K., Pasquini, M., DiPersio, J. F., van den Brink, M. R. M., Komanduri, K. V. & 2 others, Grupp, S. A. & Neelapu, S. S., Jan 1 2019, In : Biology of Blood and Marrow Transplantation.

    Research output: Contribution to journalReview article

    Open Access
  • 107 Scopus citations

    Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial

    Wilky, B. A., Trucco, M. M., Subhawong, T. K., Florou, V., Park, W., Kwon, D., Wieder, E. D., Kolonias, D., Rosenberg, A. E., Kerr, D. A., Sfakianaki, E., Foley, M., Merchan, J. R., Komanduri, K. V. & Trent, J. C., Jun 1 2019, In : The Lancet Oncology. 20, 6, p. 837-848 12 p.

    Research output: Contribution to journalArticle

  • 15 Scopus citations
  • 2 Scopus citations

    Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)

    Kansagra, A. J., Frey, N. V., Bar, M., Laetsch, T. W., Carpenter, P. A., Savani, B. N., Heslop, H. E., Bollard, C. M., Komanduri, K. V., Gastineau, D. A., Chabannon, C., Perales, M. A., Hudecek, M., Aljurf, M., Andritsos, L., Barrett, J. A., Bachanova, V., Bonini, C., Ghobadi, A., Gill, S. I. & 21 others, Hill, J. A., Kenderian, S., Kebriaei, P., Nagler, A., Maloney, D., Liu, H. D., Shah, N. N., Kharfan-Dabaja, M. A., Shpall, E. J., Mufti, G. J., Johnston, L., Jacoby, E., Bazarbachi, A., DiPersio, J. F., Pavletic, S. Z., Porter, D. L., Grupp, S. A., Sadelain, M., Litzow, M. R., Mohty, M. & Hashmi, S. K., Jan 1 2019, (Accepted/In press) In : Bone Marrow Transplantation.

    Research output: Contribution to journalArticle

  • 7 Scopus citations